[Individual choice of treatment in patients with progressive infiltrative ophthalmopathy in Graves-Basedow disease]. 1993

K Pilarska, and S Czekalski, and A Syrenicz, and W Andrzejewska, and A Ciechanowicz, and Z Krzystolik
Kliniki Endokrynologii i ChorĂ³b Przemiany Materii PAM, Szczecinie.

The results of different methods of treatment of infiltrative endocrine ophthalmopathy in 68 patients (52 women and 16 men) aged 28-63 years were evaluated. The analysis of the results indicates that combined treatment with glucocorticoids and tele-cobalt therapy may be considered as the method of choice. In patients with rapidly progressive ophthalmopathy and in patients with inactive peptic ulcer intravenous pulsed glucocorticoid administration may be used instead of oral treatment. When contraindications to corticotherapy exist, good results of treatment may be achieved with tele-cobalt therapy alone. Plasmapheresis seems less effective but may be used in rapidly progressive, short term lasting ophthalmopathy in patients refusing tele-cobalt therapy, in connection with glucocorticoids or after unsuccessful glucocorticoid therapy alone. The consecutive treatment with glucocorticoids and tele-cobalt therapy is effective but requires much more time.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010956 Plasmapheresis Procedure whereby plasma is separated and extracted from anticoagulated whole blood and the red cells retransfused to the donor. Plasmapheresis is also employed for therapeutic use. Double Filtration Plasmapheresis,Therapeutic Immunoadsorption,Therapeutic Plasma Adsorption,Therapeutic Plasmapheresis,Adsorption, Therapeutic Plasma,Adsorptions, Therapeutic Plasma,Double Filtration Plasmaphereses,Filtration Plasmapheresis, Double,Immunoadsorption, Therapeutic,Plasma Adsorption, Therapeutic,Plasmaphereses,Plasmapheresis, Double Filtration,Plasmapheresis, Therapeutic,Therapeutic Immunoadsorptions,Therapeutic Plasma Adsorptions,Therapeutic Plasmaphereses
D011867 Radioisotope Teletherapy A type of high-energy radiotherapy using a beam of gamma-radiation produced by a radioisotope source encapsulated within a teletherapy unit. Teleradioisotope Therapy,Teletherapy, Radioisotope,Therapy, Teleradioisotope
D003037 Cobalt Radioisotopes Unstable isotopes of cobalt that decay or disintegrate emitting radiation. Co atoms with atomic weights of 54-64, except 59, are radioactive cobalt isotopes. Radioisotopes, Cobalt
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005128 Eye Diseases Diseases affecting the eye. Eye Disorders,Eye Disease,Eye Disorder
D005260 Female Females
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid
D006111 Graves Disease A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy). Basedow's Disease,Exophthalmic Goiter,Goiter, Exophthalmic,Graves' Disease,Basedow Disease,Hyperthyroidism, Autoimmune,Basedows Disease,Disease, Basedow,Disease, Basedow's,Disease, Graves,Disease, Graves',Exophthalmic Goiters,Goiters, Exophthalmic

Related Publications

K Pilarska, and S Czekalski, and A Syrenicz, and W Andrzejewska, and A Ciechanowicz, and Z Krzystolik
June 2001, Revue medicale de Bruxelles,
K Pilarska, and S Czekalski, and A Syrenicz, and W Andrzejewska, and A Ciechanowicz, and Z Krzystolik
August 1975, Klinika oczna,
K Pilarska, and S Czekalski, and A Syrenicz, and W Andrzejewska, and A Ciechanowicz, and Z Krzystolik
January 1972, Southern medical journal,
K Pilarska, and S Czekalski, and A Syrenicz, and W Andrzejewska, and A Ciechanowicz, and Z Krzystolik
January 2009, Endokrynologia Polska,
K Pilarska, and S Czekalski, and A Syrenicz, and W Andrzejewska, and A Ciechanowicz, and Z Krzystolik
January 1984, Polski tygodnik lekarski (Warsaw, Poland : 1960),
K Pilarska, and S Czekalski, and A Syrenicz, and W Andrzejewska, and A Ciechanowicz, and Z Krzystolik
January 1987, Radiobiologia, radiotherapia,
K Pilarska, and S Czekalski, and A Syrenicz, and W Andrzejewska, and A Ciechanowicz, and Z Krzystolik
January 2000, Przeglad lekarski,
K Pilarska, and S Czekalski, and A Syrenicz, and W Andrzejewska, and A Ciechanowicz, and Z Krzystolik
January 1972, Acta ophthalmologica,
K Pilarska, and S Czekalski, and A Syrenicz, and W Andrzejewska, and A Ciechanowicz, and Z Krzystolik
January 1998, Klinika oczna,
K Pilarska, and S Czekalski, and A Syrenicz, and W Andrzejewska, and A Ciechanowicz, and Z Krzystolik
June 1947, Prensa medica argentina,
Copied contents to your clipboard!